ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,337Top JournalHybrid

Biomedicine & Pharmacotherapy

Acronym:biopha
•
Abbreviation (ISO):BIOMED. PHARMACOTHER
•
Identifier (ISSN):0753-3322(Print)/1950-6007(Online)
•
Publisher:Elsevier Masson
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend (2018–2025)

Clarivate IF trend for Biomedicine & Pharmacotherapy

WoS Q1
257103.4620183.7420194.5420206.5320217.4220227.520236.920247.52025
Annual Impact Factor Metric
Current (2025):7.5
Scopus SJR & RankScopus Q1
2.074
#1,337

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
196

196 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
1,562articles/year
96.76% Gold OA•69.64% Original Research

Aims & Scope

Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology. The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases. Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans. Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers

Topics Covered (Recognized by AI)
Medicine96%Biology94.3%Internal medicine83.8%Chemistry80.2%Genetics79.5%Biochemistry75.2%Endocrinology42.2%Pathology39%Immunology37.2%Gene34.4%Pharmacology33%Organic chemistry32.4%Cell biology30.7%Cancer research30.1%Physics26.4%Cancer26.1%Apoptosis24.4%Psychology21.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF—
Articles / Year990
Total Citations475
2025
IF7.5
Articles / Year1,074
Total Citations5,136
2024
IF6.9
Articles / Year1,660
Total Citations26,476
2023
IF7.5
Articles / Year1,891
Total Citations51,392
2022
IF7.419
Articles / Year1,561
Total Citations51,654

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,337Scopus Q1SCImago Profile
Scopus Coverage:1982-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
2.074

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
9.84

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,622 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations49,563
3-Year Documents5,006
Citable Documents4,986

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate48.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区MEDICINE, RESEARCH & EXPERIMENTAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Biomedicine & Pharmacotherapy (acronym: biopha, abbr: BIOMED. PHARMACOTHER, ISSN: 0753-3322) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Masson in France since 1982. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 2.074 (Q1), an H-index of 196.

The journal enforces rigorous peer evaluation with an average review speed of 7周, a publication frequency of Monthly, an annual output of approximately 1,562 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,622 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Masson
Publication Language
Multi-Language
Frequency
Monthly
Founding Year
1982
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: a2a9ce09-a852-436f-91bc-436f00df7482
Database Updated: 2026-10-16